Skip to main content

Table 3 Associations between stage of kidney disease, key demographics, and levels of health-related hopea

From: Association between health-related hope and adherence to prescribed treatment in CKD patients: multicenter cross-sectional study

 

HR-Hope (n = 458), Mean difference, points (95%CI)

Unadjusted

Adjusted 1b

Adjusted 2c

Stage of kidney disease

Ref.

Ref.

Ref.

(vs. non-dialysis stage 2/3)

non-dialysis Stage 4

− 7.1 (− 13.8 – − 0.4)

− 7.5 (− 14.2 – − 0.9)

−7.0 (− 13.7 – − 0.3)

non-dialysis Stage 5

−16.2 (− 25.6 – − 6.7)

−17.2 (− 26.5 – − 8.0)

−16.8 (− 26.1 – − 7.6)

dialysis, > 0 to 1 yr

− 11.8 (− 18.3 – − 5.4)

− 9.1 (− 15.5 – − 2.7)

− 7.9 (− 14.4 – − 1.4)

dialysis, > 1 to 3 yr

− 9.5 (− 15.8 – − 3.2)

−6.6 (− 12.9 – − 0.3)

−4.9 (− 11.3–1.6)

dialysis, > 3 yr

−12.5 (− 17.9 – − 7.1)

−10.1 (− 15.5 – − 4.6)

−8.8 (− 14.5 – − 3.2)

Age, yr

per 10 yr

2.3 (1.0–3.7)

2.1 (0.7–3.5)

Presence of family, yes

7.5 (2.2–12.9)

7.7 (2.3–13.1)

Working, yes

1.3 (− 2.6–5.2)

1.0 (− 2.9–4.9)

  1. aGeneral linear models were used to estimate mean differences in health-related hope scores
  2. bAdjusted for age, gender, stage of kidney disease, performance status, presence of family, and working status
  3. cAdjusted for the covariates listed in footnote b, and also for primary renal disease, diabetes, coronary artery disease, and cerebrovascular disease
  4. HR-Hope health-related hope, 95%CI 95% Confidence interval